Skip to main content

Table 3 Results of subgroup analysis of the association between adherence to statin use for GI cancer by age

From: Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea

 

30–44

45 ~ 59

60 ~ 75

HR

95% CI

HR

95% CI

HR

95% CI

Adherence Level

 non-user

Ref

–

–

Ref

–

–

Ref

–

–

 MPR < 25%

1.081

0.59

1.981

0.967

0.705

1.325

1.067

0.779

1.462

 MPR < 50%

0.501

0.169

1.486

0.762

0.523

1.111

0.727

0.498

1.063

 MPR < 75%

0.363

0.079

1.668

0.471

0.294

0.753

0.761

0.524

1.104

 MPR ≥ 75%

0.354

0.042

2.961

0.362

0.192

0.681

0.469

0.295

0.744

  1. MPR medication possession ratio, HR Hazard Ratio, 95% CI 95% confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us